Women’s Issues in Mental Health – Dr. Neil S. Kaye
Women’s Issues in Mental Health – Dr. Neil S. Kaye – “Psychiatry: Ask the Expert” with Dr. Neil S. Kaye Dr Kaye, and guest Jay Birch have aired a series of specialty call-in radio programs focusing on the clinical aspects of mental health and psychiatry. These programs are archived here for reference and listening. In This Edition: Women’s Issues in Mental Health Lee S. Cohen, MD is Associate Professor of psychiatry at Harvard Medical School and Director of the Perinatal and Reproductive Psychiatry Clinical Research Program at Massachusetts General Hospital, both in Boston. Tune in as Drs Kaye and Cohen discuss treatment of premenstrual dysphonic disorder, the longitudinal course and treatment of psychiatric illness during pregnancy and the postpartum period, the impact of maternal psychiatric illness on child development, and management of peri and postmenopausal depression. Neil S. Kaye MD is an active clinician and expert witness. As a specialist in Forensic Psychiatry, his testimony has had a major impact in high profile cases. Neil S. Kaye, MD is Assistant Professor of Psychiatry and Human Behavior at The Thomas Jefferson University College of Medicine and a Special Guest Lecturer at Widener University School of Law. He completed a residency in psychiatry at the Albany Medical Center Hospital and Syracuse University College of Medicine. He completed a fellowship in forensic psychiatry at Syracuse University College of Medicine. He has been an Expert Reviewer for the United States Department of Justice Special …
Doctors debate value of 'fringe' heart treatment
Filed under: drug treatment programs in massachusetts
… remove calcium from hardened arteries around the heart. Chelation has long been used to treat lead poisoning but its safety and value for heart disease are unproven. The heart disease version involves a different drug that does not have government …
Read more on Fox News
Combining antiangiogenesis and anti-HER2 drugs may improve survival of …
Filed under: drug treatment programs in massachusetts
Adding an angiogenesis inhibitor to treatment with a HER2-inhibiting drug could improve outcomes for patients with HER2-positive breast cancer who develop brain metastases. In their report published online in PNAS Plus, Massachusetts General Hospital …
Read more on Bioscience Technology